[go: up one dir, main page]

ZA200606554B - Pharmaceutical composition for oral application and method for preparing thereof - Google Patents

Pharmaceutical composition for oral application and method for preparing thereof

Info

Publication number
ZA200606554B
ZA200606554B ZA200606554A ZA200606554A ZA200606554B ZA 200606554 B ZA200606554 B ZA 200606554B ZA 200606554 A ZA200606554 A ZA 200606554A ZA 200606554 A ZA200606554 A ZA 200606554A ZA 200606554 B ZA200606554 B ZA 200606554B
Authority
ZA
South Africa
Prior art keywords
preparing
pharmaceutical composition
oral application
composition
oral
Prior art date
Application number
ZA200606554A
Other languages
English (en)
Inventor
Mattern Claudia
Pieper Wilfried
Original Assignee
Cum Pharma Consulting Anstalt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cum Pharma Consulting Anstalt filed Critical Cum Pharma Consulting Anstalt
Publication of ZA200606554B publication Critical patent/ZA200606554B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
ZA200606554A 2004-02-20 2005-02-09 Pharmaceutical composition for oral application and method for preparing thereof ZA200606554B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04003906A EP1566173B1 (en) 2004-02-20 2004-02-20 Pharmaceutical composition for oral application and method for preparing thereof

Publications (1)

Publication Number Publication Date
ZA200606554B true ZA200606554B (en) 2008-05-28

Family

ID=34707350

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200606554A ZA200606554B (en) 2004-02-20 2005-02-09 Pharmaceutical composition for oral application and method for preparing thereof

Country Status (16)

Country Link
US (1) US7767228B2 (xx)
EP (2) EP1566173B1 (xx)
JP (1) JP4800225B2 (xx)
AT (1) ATE336230T1 (xx)
AU (1) AU2005215108B2 (xx)
BR (1) BRPI0507848A (xx)
CA (1) CA2554640C (xx)
DE (1) DE602004001969T2 (xx)
DK (1) DK1566173T3 (xx)
ES (1) ES2271714T3 (xx)
NO (1) NO20064240L (xx)
PT (1) PT1566173E (xx)
RU (1) RU2342936C2 (xx)
SI (1) SI1566173T1 (xx)
WO (1) WO2005079759A2 (xx)
ZA (1) ZA200606554B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006122835A1 (en) * 2005-05-18 2006-11-23 Da Volterra Colonic delivery of adsorbents
US8048413B2 (en) 2006-05-17 2011-11-01 Helene Huguet Site-specific intestinal delivery of adsorbents, alone or in combination with degrading molecules
UY31410A1 (es) * 2007-10-30 2009-05-29 Composicion que comprende acidos grasos poliinsaturados y carbon vegetal activado
JP2010106007A (ja) * 2008-08-14 2010-05-13 Sony Corp 薬剤徐放剤、吸着剤、機能性食品、マスク及び吸着シート
NZ593217A (en) * 2008-12-05 2013-05-31 Bayer Ip Gmbh Extrudate having spicular active substances
HU231017B1 (hu) 2012-05-08 2019-11-28 LAVET Gyógyszeripari Kft. Praziquantel tartalmú ízfedett formulációk
RU2514056C2 (ru) * 2012-08-21 2014-04-27 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования Курская государственная сельскохозяйственная академия имени профессора И.И. Иванова Министерства сельского хозяйства Российской Федерации Способ инкапсуляции фенбендазола
JP6472341B2 (ja) * 2015-06-26 2019-02-20 株式会社トーヨー技術研究所 固形状の魚類用経口投与薬剤、当該薬剤を含む養魚用飼料、および当該薬剤を魚に投与する方法
CA3191671A1 (en) 2020-09-04 2022-03-10 Elanco Us Inc. Palatable formulations
CN117915955A (zh) * 2021-08-31 2024-04-19 株式会社东洋技术研究所 水栖动物用经口给药药剂
WO2023032049A1 (ja) * 2021-08-31 2023-03-09 株式会社トーヨー技術研究所 水棲動物用経口投与薬剤

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1879601A (en) * 1926-03-13 1932-09-27 Merck & Co Inc Iodine composition
NL294490A (xx) * 1962-06-25
US3709833A (en) * 1970-08-21 1973-01-09 Owens Illinois Inc Process for preparing high purity silicon oxide porous beads doped with small quantities of other oxides
US4581232A (en) * 1983-07-20 1986-04-08 Warner-Lambert Company Magnesium trisilicate suitable for preparation of medicament adsorbates
SU1465052A1 (ru) * 1985-06-10 1989-03-15 Институт Зоологии Ан Казсср Способ профилактики и лечени гельминтозов животных
US5013716A (en) * 1988-10-28 1991-05-07 Warner-Lambert Company Unpleasant taste masking compositions and methods for preparing same
UA2156A1 (uk) * 1990-05-29 1994-12-26 Інститут Хімії Поверхні Ан України Антгельминтний засіб для лікування нематодозів овець
JPH05238930A (ja) * 1992-02-28 1993-09-17 Eisai Co Ltd 持続性薬剤
RU2092155C1 (ru) * 1993-06-22 1997-10-10 Валентина Ивановна Ходак Способ получения твердого лекарственного препарата для перорального введения
US5585115A (en) * 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
IL116674A (en) * 1995-01-09 2003-05-29 Mendell Co Inc Edward Microcrystalline cellulose-based excipient having improved compressibility, pharmaceutical compositions containing the same and methods for the preparation of said excipient and of solid dosage form thereof
US5827497A (en) * 1996-08-14 1998-10-27 Mayo Foundation For Medical Education And Research Charcoal-radionuclide agents for measurement of gastrointestinal transit
ES2203963T3 (es) * 1997-05-30 2004-04-16 Osmotica Corp. Dispositivo osmotico multicapa.
DE19726412A1 (de) * 1997-06-21 1998-12-24 Merck Patent Gmbh Implantatmaterial mit einer Träger-Wirkstoff-Kombination
US6565885B1 (en) * 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
JP3834732B2 (ja) * 1998-08-05 2006-10-18 株式会社ロッテ チューインガム
US6555139B2 (en) * 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
US6352721B1 (en) * 2000-01-14 2002-03-05 Osmotica Corp. Combined diffusion/osmotic pumping drug delivery system
US6491949B2 (en) * 2000-01-14 2002-12-10 Osmotica Corp. Osmotic device within an osmotic device
EP1362583A1 (de) * 2002-05-15 2003-11-19 CUM Taste Masking AG Verfahren zur Geschmacksmaskierung von Substanzen durch Mikroverkapselung
US7001889B2 (en) * 2002-06-21 2006-02-21 Merial Limited Anthelmintic oral homogeneous veterinary pastes
US20060141009A1 (en) * 2002-08-13 2006-06-29 Sebastien Huron Novel compositions and processes for delivering an additive
AU2003280670A1 (en) * 2002-10-31 2004-05-25 Matsushita Electric Industrial Co., Ltd. Porous electrode and electrochemical device using the same

Also Published As

Publication number Publication date
AU2005215108A1 (en) 2005-09-01
WO2005079759A2 (en) 2005-09-01
ES2271714T3 (es) 2007-04-16
DE602004001969D1 (de) 2006-09-28
CA2554640A1 (en) 2005-09-01
AU2005215108B2 (en) 2010-10-07
EP1566173A1 (en) 2005-08-24
WO2005079759A3 (en) 2006-06-15
US20050186272A1 (en) 2005-08-25
JP4800225B2 (ja) 2011-10-26
CA2554640C (en) 2011-04-12
JP2007523108A (ja) 2007-08-16
BRPI0507848A (pt) 2007-07-10
PT1566173E (pt) 2006-12-29
RU2006133543A (ru) 2008-04-10
SI1566173T1 (sl) 2006-12-31
EP1566173B1 (en) 2006-08-16
EP1715850A2 (en) 2006-11-02
US7767228B2 (en) 2010-08-03
NO20064240L (no) 2006-11-20
DE602004001969T2 (de) 2007-03-15
ATE336230T1 (de) 2006-09-15
DK1566173T3 (da) 2006-12-27
RU2342936C2 (ru) 2009-01-10

Similar Documents

Publication Publication Date Title
EE200300329A (et) Meetod peroraalselt manustatavate epotiloonide biosaadavuse suurendamiseks ning selles kasutatav komplekt, ravimkoostis ja farmatseutiline ravimvorm
WO2008064353A3 (en) 7,8-saturated-4,5-epoxy-morphinanium analogs
MXPA04004464A (es) Compuestos de heteroarilo sustituido con azabiciclo para el tratamiento de enfermedades.
EE200300373A (et) Meetod kamptotetsiini analoogide sünteesimiseks kasutatavate ühendite valmistamiseks ning kamptotetsiini analoogide terviksüntees
WO2004014322A3 (en) Immunomodulatory compositions, methods of making, and methods of use thereof
WO2008044243A3 (en) Novel process for the preparation of statins and their pharmaceutically acceptable salts thereof
MY148429A (en) Novel 1,4-benzothiepin-1,1-dioxide derivatives which are substituted with benzyl groups, method for producing drugs containing said compounds and use thereof
ZA200606554B (en) Pharmaceutical composition for oral application and method for preparing thereof
PL370292A1 (en) Formulations for oral administration of active compounds
WO2004100865A3 (en) New benzimidazole derivatives
AR040021A1 (es) (s)-4-amino-5-cloro-2-metoxi-n-[1-[1-(2-tetrahidrofuril-carbonil)-4-piperidinilmetil]-4-piperidinil]benzamida, procedimiento para su preparacion, composicion farmaceutica que la contiene, e intermediarios para su preparacion
WO2007129066A8 (en) 4- (2,6-dichloro-benzoylamino) -1h-pyrazole-3-carboxylic acid (1-methanesulphonyl-piperidin-4-yl) -amide for the treatment of cancer
AU2003230189A1 (en) Oral controlled release pharmaceutical composition containing metaxalone as active agent
AU2002343661A1 (en) Modified prostaglandin compounds and analogs thereof, compositions containing the same useful for the teatment of cancer
DE502005007459D1 (de) SUBSTITUIERTE 1,4,8-TRIAZASPIROi4.5 DECAN-2-ON-VERBINDUNGEN
MX2008001560A (es) Nuevos compuestos analogos de la camptotecina, un procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
TW200640465A (en) New pharmaceutically active compounds for the treatment of respiratory diseases
HUP0204430A3 (en) Method for the enzymatic resolution of the racemates of aminomethyl-aryl-cyclohexanol derivatives, the obtained new compounds and pharmaceutical compositions containing thereof
AU2002338953A1 (en) Method for the production of solid formulations of sodium 3-hydroxy-3-methylbutyrate
WO2007080117A3 (de) Schichtsilicatformulierung für eine kontrollierte wirkstofffreisetzung
AU2003270202A1 (en) Pharmaceutical compositions increasing camp useful for the treatment of cancers
AU2003281176A1 (en) Medicinal composition for mitigating blood lipid or lowering blood homocystein
TW200640933A (en) Anthelmintic compounds
ATE295358T1 (de) N-benzylpiperazin n-benzylpiperazine, verbindungen, verfahren zu deren herstellung und deren pharmazeutischen zusammensetzungen
WO2004083172A3 (en) Process for the preparation of 7-amino (p-hydroxyphenylglyclyamido) cephem compounds